CERo Therapeutics Inc.
(CERO) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.06
1.05%
Pre-market Jan 06, 2025, 07:00 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 |
PE Ratio | -28.31K | -104.12 | -721.74 |
PS Ratio | n/a | n/a | n/a |
PB Ratio | -5.06 | 28.16 | 1.33 |
P/FCF Ratio | -47.25K | -38.92 | -173.89 |
P/OCF Ratio | -47.13K | -63.65 | -326.7 |
OCF/S Ratio | n/a | n/a | n/a |
Debt / Equity Ratio | -0.11 | 0.26 | 0.02 |
Quick Ratio | 1.65 | 1.38 | 13.88 |
Current Ratio | 1.65 | 1.38 | 13.88 |
Asset Turnover | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a |
Return on Equity (ROE) | 0.00 | -0.27 | -0.00 |
Return on Assets (ROA) | -0.00 | -0.02 | -0.00 |
Return on Capital (ROIC) | -0.87 | -0.25 | -0.00 |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a |